Approval · Notice of Compliance 33062 · 2024
VABYSMO: Notice of Compliance 33062
Issued April 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33062
- Date
- April 15, 2024
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VABYSMO | Not yet assigned | — |
Medicinal ingredients
- FARICIMAB 6 MG per 0.05ML